Pain Relief Patches

Description

This product is packaged in a box containing 60 units. The National Drug Code (NDC) for this formulation is 0363-0907-60. It is recommended to store the product in a clean, dry place, away from direct sunlight, and to protect it from excessive moisture to maintain its integrity.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and over, the affected area should be cleaned and dried prior to application. The patch should be removed from its protective film and applied to the affected area. It is recommended that the patch be applied no more than 3 to 4 times daily. Each patch should be removed from the skin after a maximum application duration of 8 hours.

For children under 12 years of age, it is advised to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

• Application on wounds or damaged skin is prohibited due to the risk of exacerbating the condition and causing further irritation.

• Concurrent use with a heating pad is contraindicated as it may lead to increased absorption and potential adverse effects.

• Individuals with known allergies to any ingredients in this product should not use it to prevent allergic reactions.

Additionally, avoid contact with eyes, mucous membranes, or rashes, and do not apply tightly bandaged. The simultaneous use of other topical analgesics is also contraindicated to prevent potential interactions.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to consult a physician prior to use if they have a known allergy to aspirin or salicylates, as this product may provoke an allergic reaction in susceptible individuals.

It is imperative to avoid application on wounds or damaged skin to prevent adverse effects. Additionally, the use of this product in conjunction with a heating pad is contraindicated, as it may lead to increased irritation or other complications. Patients should also be cautioned against using the product if they are allergic to any of its ingredients.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be instructed to discontinue use and consult a healthcare provider if they experience any of the following: rash, itching, or excessive skin irritation. Furthermore, if the condition worsens or if symptoms persist beyond 7 days, or if symptoms resolve only to recur within a few days, medical advice should be sought promptly.

Side Effects

Patients should be aware of the potential for allergic reactions, particularly if they have a history of sensitivity to aspirin or salicylates. It is advisable for these individuals to consult a healthcare professional prior to use.

In the event that patients experience a rash, itching, or excessive skin irritation, they should discontinue use and seek medical advice. Additionally, if the condition worsens or if symptoms persist beyond 7 days, or if symptoms resolve and then recur within a few days, it is important to consult a doctor. These recommendations are crucial for ensuring patient safety and effective management of any adverse reactions that may arise during treatment.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated. The combination may increase the risk of adverse effects without providing additional therapeutic benefit. It is advised to avoid using multiple topical analgesics simultaneously to ensure patient safety and efficacy of treatment. Monitoring for any signs of irritation or adverse reactions is recommended if there is a need to switch to or from another topical analgesic.

Packaging & NDC

Below are the non-prescription pack sizes of Pain Relief Patches (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a physician prior to use. For patients aged 12 years and older, the recommended application involves cleaning and drying the affected area, followed by the removal of the patch from its film and application to the affected area. The patch may be applied no more than 3 to 4 times daily, with a maximum wear time of 8 hours.

It is crucial to dispose of used patches in a manner that prevents access by children and pets, as they still contain the drug product, which can lead to serious adverse effects if ingested. Additionally, the product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy.

Pregnancy

Safety during pregnancy has not been established for this product. Pregnant patients or those planning to become pregnant should consult a healthcare provider prior to use. While potential risks to the fetus are not clearly defined, caution is advised when considering the use of this product during pregnancy. There are no specific dosage modifications recommended for pregnant individuals. It is essential to use this product only if clearly needed and after a thorough discussion with a healthcare provider regarding the potential risks and benefits.

Lactation

There are no specific statements regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from excessive dosing. Symptoms of overdosage can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and intervention strategies.

Documentation of the incident, including the amount ingested and the time of ingestion, is crucial for effective treatment planning.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad.

Patients should be informed of the potential for allergic reactions and advised not to use the product if they are allergic to any of its ingredients. They should be instructed to discontinue use and consult a doctor if they experience rash, itching, or excessive skin irritation. Additionally, patients should be made aware that they should stop using the product and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

When using the product, patients must be reminded to follow the directions provided and to avoid contact with eyes, mucous membranes, or rashes. They should also be cautioned against bandaging the area tightly and using the product simultaneously with other topical analgesics.

Finally, healthcare providers should emphasize the importance of proper disposal of used patches, ensuring that they are kept out of reach of children and pets, as these patches may still contain active drug substances that could lead to serious adverse effects if ingested.

Storage and Handling

The product is supplied in a clean, dry package designed to protect it from direct sunlight and excessive moisture. It is essential to store the product in a location that maintains these conditions to ensure its integrity and effectiveness.

After use, the patch must be disposed of properly to prevent access by children and pets, ensuring safety in the environment.

Additional Clinical Information

Patients should apply the topical patch to a clean and dry affected area, using it no more than 3 to 4 times daily. The patch should be removed after a maximum of 8 hours of application. For children under 12 years of age, consultation with a physician is recommended prior to use.

Clinicians should advise patients with a history of allergic reactions to aspirin or salicylates to consult a doctor before using the product. It is important to instruct patients on the safe disposal of used patches to prevent accidental ingestion by children or pets, as these patches may still contain active drug that can lead to serious adverse effects. Patients should discontinue use and seek medical advice if they experience rash, itching, excessive skin irritation, worsening of their condition, or if symptoms persist beyond 7 days or recur after resolution. Additionally, patients should keep the product out of reach of children and seek immediate medical assistance or contact a Poison Control Center if the patch is swallowed.

Drug Information (PDF)

This file contains official product information for Pain Relief Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)